Evaluation of Effects of Dextrometorphan and Midazolam onMorphin-Induced Tolerance and Dependence in Mice Morphine tolerance and dependence
Iranian Journal of Pharmaceutical Sciences,
Vol. 4 No. 4 (2008),
1 October 2008
,
Page 253-260
https://doi.org/10.22037/ijps.v4.41051
Abstract
Long-term exposure to opiates induces physical dependence and tolerance. The main goal of this study was to evaluate the effects of dextromethorphan and midazolam and their combination on morphine tolerance and dependence in mice.Different groups of mice were rendered randomly and received morphine (50mg/kg, sc), morphine (50 mg/kg, sc) + dextromethorphan (25,50 or 75 mg/kg, ip),morphine (50 mg/kg, sc) + midazolam (0.5, 1, 2 mg/kg, ip), morphine (50 mg/kg,sc) + dextromethorphan (25 mg/kg, ip) + midazolam (0.5 mg/kg, ip) once a day for four days. Tolerance was assessed by administration of morphine (9 mg/kg, ip) onthe fifth day. Withdrawal symptoms (markers for dependence) was assessed byadministration of naloxone (4 mg/kg, ip) two hours after co-administration ofmorphine with either dextromethorphan or midazolam or their combination groups. Results showed that pretreatment with dextromethorphan or midazolam decreased the degree of tolerance and withdrawal symptoms significantly.Additionally, co-administration of dextromethorphan and midazolam before morphine administration decreased the tolerance and dependence but it was not significant.From these results, it may be concluded that dextromethorphan and midazolam alone or in combination could prevent the development of tolerance and dependence tothe analgesic effects of morphine. These effects can be related to the N-methyl-D-aspartate (NMDA) receptor antagonist behavior of dextromethorphan and GABA-receptor agonist behavior of midazolam.
- Dependence
- Dextromethorphan
- Midazolam
- Morphine
- Tolerance
How to Cite
References
[3]Kozela E, Popik P. The effects of NMDA receptor antagonists on acute morphine antinociceptionin mice. Amino Acids2002; 23: 163-8.
[4]Elliott K, Kest B, Man A, Inturrisi CE. N-Methyl-D-Aspartate (NMDA) receptors, mu and kappa opioid tolerance and perspectives on new analgesic drug development. Neuropharmacolo-gy1995; 13: 347-56.[5]George FK. Neuroadaptive mechanisms of addiction: Study on the extended amigdala. Neu-ropsychopharmacology2003; 13: 442-52.
[6]Eric JN, Aghajanian GK. Molecular and cellular basis of addiction. Science1997; 278: 58-63.
[7]Jaba IM, Luncanu I, Mungiu OC. Opioid tolerance and dependence-pharmacological aspects. Rev Med Chir Soc Med Nat Iasi 2001; 105: 444 -50.
[8]Liu JG, Anand KJ. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev2000;38: 1-19.
[9]Christensen D, Idaanpan-Hiekkila JJ, Guilboud G.The antinociceptive effect of morphine and the glycine/NMDAreceptor antagonis (+)-HA966in rat model of peripheral neuropathy. Br J Pharm 1998; 125: 1641-50.
[10]Rang HP, Dale MM, Ritter JM, Moore P,Pharmacology. London: Churchill Livingston,2005; pp. 594-611
[11]Chevlen E. Morphine with dextromethorphan:conversion from other opioid analgesics. J Pain Symptom Manage2000; 19: S42-9.
[12]Huang EY, Liu TC, Tao PL. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol 2003; 368: 386-92.
[13]Bossard AE, Guirimand F, Fletcher D, Gaude-Joindreau V, Chauvin M, Bouhassira D.Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain2002; 98: 47-57.
[14]Allen RM, Granger AL, Dykstra LA. Dex-tromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol ExpTher2002; 300: 435-41.[15]Manning BH, Mao J, Frenk H, Price DD, Mayer DJ. Continuous co-administration of dex-tromethorphan or MK-801 with morphine:Attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.Pain1996; 67: 79-88.
[16]Mao J, Price DD, Caruso FS, Mayer DJ. Orala dministration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain1996; 67: 361-8.
[17]Luger TJ, Lorenz IH, Grabner-Weiss C, Hayashi.Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats. Br J Pharmacol 1995; 114: 1097-103.[18]Bartlett SE, Cramond T, Smith MT. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sci1994; 54: 687-94.
[19]Habibi Asl B, Hassanzadeh K, Moosazadeh S.Effects of ketamine and magnesium on morphine induced tolerance and dependence in mice. Daru 2005; 13: 110-15.
[20]Tejwani GA, Rattan AK, Sribanditmongkol P,Sheu MJ, Zuniga J, McDonald JS. Inhibition of morphine-induced tolerance and dependence by a benzodiazepine receptor agonist midazolam in the rat. Anesth Analg1993; 76: 1052-60.
[21]Sivam SP, Ho IK. GABAin morphine analgesia and tolerance. Life Sci 1985; 37: 199-208.
[22]Cao JL, Ding HL, Zhang LC, Dung SM, Zeng YM. Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats.Acta Pharmacol Sin2002; 23: 685-90.
[23]Sheu MJ, Sribanditmongkol P, Santosa DN,Tejwani GA. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMPlevels in discrete rat brain regions and spinal cord. Brain Res1995; 675: 31-7.
[24]Sribanditmongkol P, Sheu MJ, Tejwani GA.Inhibition of morphine tolerance and dependence by diazepam and its relation to the CNS Met-enkephalinlevels.Brain Res1994; 645: 1-12.
[25]Tejwani GA, Sheu MJ, Sribanditmongkol P,Satyapriya A. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.Brain Res1998; 299: 305-12.
[26]Rattan AK, Sribanditmongkol P. Effect of morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat. Pharmacol Biochem Behav1994; 48: 357-61.[27]Pepicelli O, Brescia A, Gherzi E, Raiteri M,Fedele E. GABA(A), but not NMDA, receptor smodulatein vivoNO-mediated cGMP synthesisin the rat cerebral cortex. Neuropharmacology 2004; 46: 480-9.
[28] Habibi Asl B, Hassanzadeh K, Effects of ketamineand midazolam on morphine induced dependence and tolerance in mice. Daru2004; 12: 101-5.
[29]Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992; 12: 483-8.
[30]Gysling K, Wang RY. Morphine-induced activation of A10 dopamine neurons in the rat.Brain Res1983; 277: 119-27.
[31]Sinkkonen ST, Linden AM, Korpi ER, Wong G.Selective reduction of gamma-aminobutyric acid type Areceptor delta subunit mRNAlevels by MK-801 in rat dentate gyrus. Neurosci Lett2004;364: 106-9.
[32]Shoji Y, Delfs J, Williams JT. Presynaptic inhibition of GABA-B-mediated synaptic potentials in the VTAduring morphine withdrawal.J Neurosci1999; 19: 2347-55.
[33]Johnson SW, Mercuri NB, North RA. 5-Hydrox-ytryptamine-1b receptors block the GABA-Bsynaptic potential in rat dopamine neurons. J Neurosci 1992; 12: 2000-6.
[34]Cameron DL, Williams JT. Dopamine D1receptors facilitate transmitter release. Nature 1993; 366: 344-7.
- Abstract Viewed: 84 times
- IJPS_Volume 4_Issue 4_Pages 253-260 Downloaded: 14 times